Published in Am J Trop Med Hyg on June 01, 2000
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med (2001) 2.76
Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A (2008) 1.96
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis (2007) 1.63
Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Negl Trop Dis (2008) 1.62
Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS One (2008) 1.61
An insight into the sialome of blood-feeding Nematocera. Insect Biochem Mol Biol (2010) 1.61
Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Negl Trop Dis (2010) 1.60
Severity of old world cutaneous leishmaniasis is influenced by previous exposure to sandfly bites in Saudi Arabia. PLoS Negl Trop Dis (2015) 1.48
Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors (2011) 1.39
Prevalence of Cutaneous Leishmaniasis in Districts of High and Low Endemicity in Mali. PLoS Negl Trop Dis (2016) 1.37
An insight into the sialome of Glossina morsitans morsitans. BMC Genomics (2010) 1.34
Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control. Am J Trop Med Hyg (2010) 1.31
Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg (2010) 1.30
Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites. Malar J (2009) 1.25
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. PLoS Negl Trop Dis (2010) 1.25
Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PLoS One (2010) 1.25
Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors. PLoS One (2011) 1.24
An insight into immunogenic salivary proteins of Anopheles gambiae in African children. Malar J (2007) 1.21
Sand flies, Leishmania, and transcriptome-borne solutions. Parasitol Int (2008) 1.16
Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis. Am J Trop Med Hyg (2011) 1.14
Antibody responses of domestic animals to salivary antigens of Triatomainfestans as biomarkers for low-level infestation of triatomines. Int J Parasitol (2009) 1.12
Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control? PLoS Med (2007) 1.11
Immunobiology of visceral leishmaniasis. Front Immunol (2012) 1.10
The immune response to sand fly salivary proteins and its influence on leishmania immunity. Front Immunol (2012) 1.10
Canine antibody response to Phlebotomus perniciosus bites negatively correlates with the risk of Leishmania infantum transmission. PLoS Negl Trop Dis (2011) 1.10
IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk. PLoS One (2012) 1.06
Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells. Infect Immun (2004) 1.03
IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal. Malar J (2012) 1.03
Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phlebotomus sergenti, vectors of leishmaniasis. PLoS Negl Trop Dis (2012) 1.02
Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E₂ production in murine macrophages. PLoS Negl Trop Dis (2010) 1.02
Immunogenic salivary proteins of Triatoma infestans: development of a recombinant antigen for the detection of low-level infestation of triatomines. PLoS Negl Trop Dis (2009) 0.99
Salivary antigen SP32 is the immunodominant target of the antibody response to Phlebotomus papatasi bites in humans. PLoS Negl Trop Dis (2012) 0.96
An insight into the sialotranscriptome of the West Nile mosquito vector, Culex tarsalis. BMC Genomics (2010) 0.94
Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins. PLoS One (2013) 0.92
Kinetics of antibody response in BALB/c and C57BL/6 mice bitten by Phlebotomus papatasi. PLoS Negl Trop Dis (2012) 0.92
Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination. PLoS One (2012) 0.92
gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas. Parasit Vectors (2013) 0.92
Sand-fly saliva-leishmania-man: the trigger trio. Front Immunol (2013) 0.92
Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen. Am J Trop Med Hyg (2010) 0.91
What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity. Infect Genet Evol (2014) 0.91
DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis. Acta Trop (2011) 0.89
In silico identification of a candidate synthetic peptide (Tsgf118-43) to monitor human exposure to tsetse flies in West Africa. PLoS Negl Trop Dis (2013) 0.88
Comparative analysis of salivary gland transcriptomes of Phlebotomus orientalis sand flies from endemic and non-endemic foci of visceral leishmaniasis. PLoS Negl Trop Dis (2014) 0.88
Biomarkers for exposure to sand flies bites as tools to aid control of leishmaniasis. Front Immunol (2012) 0.83
Identifying vaccine targets for anti-leishmanial vaccine development. Expert Rev Vaccines (2014) 0.82
Seroconversion of sentinel chickens as a biomarker for monitoring exposure to visceral leishmaniasis. Sci Rep (2013) 0.81
Validation of Recombinant Salivary Protein PpSP32 as a Suitable Marker of Human Exposure to Phlebotomus papatasi, the Vector of Leishmania major in Tunisia. PLoS Negl Trop Dis (2015) 0.80
Production and Purification of Anti-Rhombomys opimus Immunoglobulins. Iran J Arthropod Borne Dis (2011) 0.80
Characterization of guinea pig antibody responses to salivary proteins of Triatoma infestans for the development of a triatomine exposure marker. PLoS Negl Trop Dis (2014) 0.80
Serological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity. Parasit Vectors (2015) 0.79
IgG1 and IgG4 antibody responses to the Anopheles gambiae salivary protein gSG6 in the sympatric ethnic groups Mossi and Fulani in a malaria hyperhendemic area of Burkina Faso. PLoS One (2014) 0.79
Molecular and immunogenic properties of apyrase SP01B and D7-related SP04 recombinant salivary proteins of Phlebotomus perniciosus from Madrid, Spain. Biomed Res Int (2013) 0.78
Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies. J Infect Dis (2015) 0.77
New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in Leishmaniasis. J Parasitol Res (2012) 0.77
Immunogenicity and Serological Cross-Reactivity of Saliva Proteins among Different Tsetse Species. PLoS Negl Trop Dis (2015) 0.76
Profiling of human acquired immunity against the salivary proteins of Phlebotomus papatasi reveals clusters of differential immunoreactivity. Am J Trop Med Hyg (2014) 0.76
Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area. PLoS Negl Trop Dis (2016) 0.75
Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection. PLoS Negl Trop Dis (2016) 0.75
Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species. BMC Genomics (2017) 0.75
Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and Leishmania. PLoS Negl Trop Dis (2017) 0.75
Human immune response to salivary proteins of wild-caught Phlebotomus papatasi. Parasitol Res (2016) 0.75
The sequence of the human genome. Science (2001) 101.55
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A (1992) 5.94
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst (2001) 5.09
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science (1988) 4.10
PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res (1996) 3.74
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol (1997) 3.60
Antibody testing in Lyme disease. A comparison of results in four laboratories. JAMA (1990) 3.20
Tissue microarray: a new technology for amplification of tissue resources. Cancer J (2001) 3.19
Methodological concerns and recommendations on policy consequences of the World Health Report 2000. Lancet (2001) 3.04
Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae). J Med Entomol (1987) 3.00
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet (1989) 2.94
A database of vertebrate longevity records and their relation to other life-history traits. J Evol Biol (2009) 2.93
Role of saliva in blood-feeding by arthropods. Annu Rev Entomol (1987) 2.78
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med (2001) 2.76
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med (1990) 2.67
Comparing the relative potential of rodents as reservoirs of the Lyme disease spirochete (Borrelia burgdorferi). Am J Epidemiol (1989) 2.62
Apoptosis and disease. Lancet (1993) 2.55
Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med (2000) 2.05
Extraskeletal Ewing's sarcoma: results of combined modality treatment. J Clin Oncol (1983) 1.99
Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini. J Exp Med (1985) 1.97
Increased intradermal probing time in sporozoite-infected mosquitoes. Am J Trop Med Hyg (1984) 1.93
The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer (1984) 1.93
Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2003) 1.91
Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J Infect Dis (1992) 1.90
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun (2001) 1.90
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med (1982) 1.83
Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci U S A (1993) 1.76
Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis. Hum Gene Ther (1998) 1.76
Presence of pili in species of human and animal parasites and pathogens of the genuscorynebacterium. Infect Immun (1976) 1.74
Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis. J Biol Chem (2000) 1.73
Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg (1991) 1.71
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med (1982) 1.67
Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med (1998) 1.63
BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology (1991) 1.63
[Health inequalities in Barcelona and Valencia]. Med Clin (Barc) (1993) 1.61
Exploring the transcriptome of the malaria sporozoite stage. Proc Natl Acad Sci U S A (2001) 1.59
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc Natl Acad Sci U S A (1999) 1.59
Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly? Proc Natl Acad Sci U S A (2000) 1.58
Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis. Proc Natl Acad Sci U S A (1999) 1.57
The salivary gland-specific apyrase of the mosquito Aedes aegypti is a member of the 5'-nucleotidase family. Proc Natl Acad Sci U S A (1995) 1.56
Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer (1992) 1.56
Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg (1977) 1.55
Combined small-cell and transitional cell carcinoma of the renal pelvis. A light microscopic, immunohistochemical, and ultrastructural study of a case with literature review. Arch Pathol Lab Med (1993) 1.53
Immunoglobulin binding to herpes virus-induced Fc receptors inhibits virus growth. Nature (1977) 1.50
Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet (1995) 1.49
The role of vector saliva in transmission of arthropod-borne disease. Parasitol Today (1990) 1.48
Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ (1999) 1.46
Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun (1991) 1.46
Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology (1993) 1.44
Exploring the sialome of the blood-sucking bug Rhodnius prolixus. Insect Biochem Mol Biol (2004) 1.41
Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection. J Viral Hepat (2006) 1.40
The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J Exp Biol (2001) 1.40
Chitinases of the avian malaria parasite Plasmodium gallinaceum, a class of enzymes necessary for parasite invasion of the mosquito midgut. J Biol Chem (2000) 1.39
An efficient locally affine framework for the smooth registration of anatomical structures. Med Image Anal (2008) 1.38
Characteristics of the Fc receptor induced by herpes simplex virus. Intervirology (1978) 1.38
Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A (1994) 1.36
Agglutination of trypsinized sheep erythrocytes by the pili of Corynebacterium renale. Infect Immun (1974) 1.34
Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res (1995) 1.33
Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J Immunol (1997) 1.33
Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J Biol Chem (1991) 1.32
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
Role of sand fly saliva in human and experimental leishmaniasis: current insights. Scand J Immunol (2007) 1.30
Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery (1985) 1.30
Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis (1996) 1.29
Gastric dysplasia. A histological follow-up study. Am J Surg Pathol (1987) 1.28
Purification, cloning, and expression of an apyrase from the bed bug Cimex lectularius. A new type of nucleotide-binding enzyme. J Biol Chem (1998) 1.28
Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med (1983) 1.27
Salivary apyrase of Aedes aegypti: characterization and secretory fate. Comp Biochem Physiol B (1984) 1.27
Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry (1997) 1.27
Properties of the cell surface Fc-receptor induced by herpes simplex virus. J Immunol (1978) 1.26
The D7 family of salivary proteins in blood sucking diptera. Insect Mol Biol (2002) 1.25
Role of mosquito saliva in blood vessel location. J Exp Biol (1984) 1.24
Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg (1995) 1.24
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery (1978) 1.23
Idiopathic entero-colic lymphocytic phlebitis. A cause of ischemic intestinal necrosis. Am J Surg Pathol (1989) 1.23
Anti-tick antibodies: an epidemiologic tool in Lyme disease research. Am J Epidemiol (1990) 1.23
Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis (2006) 1.23
K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol (1994) 1.23
Presence of human papilloma viral antigens in juvenile multiple laryngeal papilloma. Am J Clin Pathol (1981) 1.22
Purification, cloning, expression, and mechanism of action of a novel platelet aggregation inhibitor from the salivary gland of the blood-sucking bug, Rhodnius prolixus. J Biol Chem (2000) 1.22
Modulation transfer function evaluation of cone beam computed tomography for dental use with the oversampling method. Dentomaxillofac Radiol (2010) 1.22
Characterization of a blood activated chitinolytic system in the midgut of the sand fly vectors Lutzomyia longipalpis and Phlebotomus papatasi. Insect Mol Biol (2005) 1.20
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol (1997) 1.19
Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol (1989) 1.19
Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex. Insect Mol Biol (1999) 1.19
Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients. Clin Rheumatol (2009) 1.19
Crystal structure of plant aspartic proteinase prophytepsin: inactivation and vacuolar targeting. EMBO J (1999) 1.18
Isoelectric points of proteins: theoretical determination. Anal Biochem (1989) 1.18
High-grade soft tissue sarcomas of the extremities. Cancer (1986) 1.18